MedTrace Logo

Infantile NO Replenishment as a New Therapeutic Possibility

NCT04914806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2022-12-21

No results posted yet for this study

Summary

Case-control study of inhaled Nitric Oxide (iNO) treatment of full-term and preterm infants. The main objective of this study is to investigate the association between premature birth and its later comorbidities (neuroendocrine, metabolic, cognitive, etc) with iNO treatment and the maturation of the HPG axis during minipuberty.

Conditions

  • Prematurity
  • Respiratory Distress Syndrome, Newborn

Sponsors & Collaborators

  • URI-NKUA

    collaborator UNKNOWN

  • University Hospital, Lille

    collaborator OTHER

  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • George P. Chrousos, Professor · URI-NKUA, Athens, Greece, 11527

Eligibility

Min Age
1 Day
Max Age
3 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • France
  • Greece
  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04914806 on ClinicalTrials.gov